Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.5.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.5.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.41NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.41NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.75.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CR.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CR.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CR.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BT.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BT.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BT.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FS.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.54NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.15 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.15 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.15 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.348NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.1.348NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.348NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-13865.4China
B.1.575NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used